- $9.37bn
- $9.70bn
- $1.53bn
Masimo's Joe Kiani resigns as CEO after board ouster
Masimo shareholders elect both Politan nominees in bitter boardroom battle
Brief: Leading Proxy Advisory Firm Glass Lewis Reiterates Recommendation That Masimo Shareholders Vote For Both Of Politan’s Independent Director Nominees
Brief: Masimo Corp Says Urging Stockholders To Vote "For" Only Co's Director Nominees, Joe Kiani And Christopher Chavez
Brief: Politan Comments On Masimo's Latest Attempt To Block A Fair Shareholder Vote
Brief: Masimo Says Partners With Google To Develop A Reference Platform
Brief: Masimo Issues Statement Following Court's Order Holding Politan And Quentin Koffey In Contempt And Finding Politan Made False Statements To Stockholders
Brief: Politan Issues Statement From Legal Advisors On Masimo Proxy Contest
Brief: Leading Proxy Advisory Firm Egan-Jones Recommends Stockholders Vote “For” Masimo’s Director Nominees, Joe Kiani And Christopher Chavez
Brief: Masimo Says Urging Stockholders To Vote "For" Company's Director Nominees
Media: Masimo, under activist pressure, subpoenaed two top proxy advisors for private investor communications - CNBC
Brief: Masimo Partners With March Of Dimes To Help Parents With Babies In The Nicu Make The Transition From Hospital To Home
Brief: Masimo Corp Separately Received Unsolicited Inbound Requests From Other Potential Acquirors Of Its Consumer Audio Business
Brief: Masimo Corp Files Revised Definitive Proxy Materials And Mails Letter To Stockholders
Masimo Corp reports results for the quarter ended in June - Earnings Summary
Brief: Masimo Q2 Adjusted Net Income USD 46.6 Million Vs. IBES Estimate USD 42 Million
Masimo Corp expected to post earnings of 76 cents a share - Earnings Preview
Activist investor Politan files lawsuit against medical device maker Masimo (updated)
Activist investor Politan files lawsuit against Masimo